These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17548443)

  • 1. Treatment of depression in people who have multiple sclerosis.
    Sollom AC; Kneebone II
    Mult Scler; 2007 Jun; 13(5):632-5. PubMed ID: 17548443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant use in multiple sclerosis: epidemiologic study of a large community sample.
    Cetin K; Johnson KL; Ehde DM; Kuehn CM; Amtmann D; Kraft GH
    Mult Scler; 2007 Sep; 13(8):1046-53. PubMed ID: 17623732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of self-chosen therapies by depressed people in primary care.
    Badger F; Nolan P
    J Clin Nurs; 2007 Jul; 16(7):1343-52. PubMed ID: 17584353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in people with multiple sclerosis: data from the Sonya Slifka Longitudinal Multiple Sclerosis Study.
    Wu N; Minden SL; Hoaglin DC; Hadden L; Frankel D
    J Health Hum Serv Adm; 2007; 30(3):233-67. PubMed ID: 18236703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Depression in multiple sclerosis].
    Lebrun C; Cohen M
    Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S156-62. PubMed ID: 19361681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased rate of treatment with antidepressants in patients with multiple sclerosis.
    Kessing LV; Harhoff M; Andersen PK
    Int Clin Psychopharmacol; 2008 Jan; 23(1):54-9. PubMed ID: 18090509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression in multiple sclerosis: a quantitative review of the evidence.
    Dalton EJ; Heinrichs RW
    Neuropsychology; 2005 Mar; 19(2):152-8. PubMed ID: 15769199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients.
    Lueboonthavatchai P
    J Med Assoc Thai; 2007 Oct; 90(10):2164-74. PubMed ID: 18041438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation study of prevalence and correlates of depressive symptomatology in multiple sclerosis.
    Bamer AM; Cetin K; Johnson KL; Gibbons LE; Ehde DM
    Gen Hosp Psychiatry; 2008; 30(4):311-7. PubMed ID: 18585533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-depressant use in association with interferon and glatiramer acetate treatment in multiple sclerosis.
    Patten SB; Williams JV; Metz LM
    Mult Scler; 2008 Apr; 14(3):406-11. PubMed ID: 17986504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression in multiple sclerosis: reactive or endogenous?
    Holden K; Isaac CL
    Clin Neuropsychol; 2011 May; 25(4):624-39. PubMed ID: 21432735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of intervention studies on depression in persons with multiple sclerosis.
    Walker ID; Gonzalez EW
    Issues Ment Health Nurs; 2007 May; 28(5):511-31. PubMed ID: 17613150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis beyond EDSS: depression and fatigue.
    Ziemssen T
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S37-41. PubMed ID: 19200865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endorsement of self-report neurovegetative items of depression is associated with multiple sclerosis disease symptoms.
    Beeney JE; Arnett PA
    J Int Neuropsychol Soc; 2008 Nov; 14(6):1057-62. PubMed ID: 18954485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatigue in multiple sclerosis: relation to depression, physical impairment, personality and action control.
    Penner IK; Bechtel N; Raselli C; Stöcklin M; Opwis K; Kappos L; Calabrese P
    Mult Scler; 2007 Nov; 13(9):1161-7. PubMed ID: 17967844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health professionals' recognition of co-occurring alcohol and depressive disorders in youth: a survey of Australian general practitioners, psychiatrists, psychologists and mental health nurses using case vignettes.
    Lubman DI; Hides L; Jorm AF; Morgan AJ
    Aust N Z J Psychiatry; 2007 Oct; 41(10):830-5. PubMed ID: 17828656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized group intervention trial to enhance mood and self-efficacy in people with multiple sclerosis.
    Rigby SA; Thornton EW; Young CA
    Br J Health Psychol; 2008 Nov; 13(Pt 4):619-31. PubMed ID: 17845738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensory complaints of the upper extremities in multiple sclerosis: relative efficacy of nortriptyline and transcutaneous electrical nerve stimulation.
    Chitsaz A; Janghorbani M; Shaygannejad V; Ashtari F; Heshmatipour M; Freeman J
    Clin J Pain; 2009 May; 25(4):281-5. PubMed ID: 19590475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of depression in Otocac ten years after the war].
    Marinić T; Ozvacić Z; Katić M; Polasek O; Lazić D
    Acta Med Croatica; 2007 Feb; 61(1):25-31. PubMed ID: 17593637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis.
    Brown RF; Valpiani EM; Tennant CC; Dunn SM; Sharrock M; Hodgkinson S; Pollard JD
    Psychol Psychother; 2009 Mar; 82(Pt 1):41-56. PubMed ID: 18727845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.